369 related articles for article (PubMed ID: 7829409)
21. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.
Brown BA; Wallace RJ; Onyi GO; De Rosas V; Wallace RJ
Antimicrob Agents Chemother; 1992 Jan; 36(1):180-4. PubMed ID: 1317144
[TBL] [Abstract][Full Text] [Related]
22. Activity of moxifloxacin against mycobacteria.
Gillespie SH; Billington O
J Antimicrob Chemother; 1999 Sep; 44(3):393-5. PubMed ID: 10511409
[TBL] [Abstract][Full Text] [Related]
23. Activity of quinolones against mycobacteria.
Jacobs MR
Drugs; 1999; 58 Suppl 2():19-22. PubMed ID: 10553700
[TBL] [Abstract][Full Text] [Related]
24. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Bauernfeind A
J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
[TBL] [Abstract][Full Text] [Related]
25. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
Kawahara S; Nagare H
Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700
[TBL] [Abstract][Full Text] [Related]
26. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
Tomioka H; Sato K; Saito H
Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
[TBL] [Abstract][Full Text] [Related]
28. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
Fenlon CH; Cynamon MH
Antimicrob Agents Chemother; 1986 Mar; 29(3):386-8. PubMed ID: 2940969
[TBL] [Abstract][Full Text] [Related]
29. Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.
Salfinger M; Hohl P; Kafader FM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():55-63. PubMed ID: 3144550
[TBL] [Abstract][Full Text] [Related]
30. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.
Tomioka H; Saito H; Sato K
Antimicrob Agents Chemother; 1993 Jun; 37(6):1259-63. PubMed ID: 8392307
[TBL] [Abstract][Full Text] [Related]
31. [Antimycobacterial activity of a newly synthesized fluoroquinolone, Y-26611].
Tomioka H; Sato K; Saito H; Ikeda Y
Kekkaku; 1992 Jul; 67(7):515-20. PubMed ID: 1331603
[TBL] [Abstract][Full Text] [Related]
32. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
[TBL] [Abstract][Full Text] [Related]
33. Activity of quinolones against mycobacteria.
Jacobs MR
Drugs; 1995; 49 Suppl 2():67-75. PubMed ID: 8549419
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.
Khardori N; Nguyen H; Rosenbaum B; Rolston K; Bodey GP
Antimicrob Agents Chemother; 1994 Jan; 38(1):134-7. PubMed ID: 8141567
[TBL] [Abstract][Full Text] [Related]
35. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
Klopman G; Fercu D; Renau TE; Jacobs MR
Antimicrob Agents Chemother; 1996 Nov; 40(11):2637-43. PubMed ID: 8913479
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
Disratthakit A; Doi N
Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403
[TBL] [Abstract][Full Text] [Related]
37. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
38. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde JL; Pocidalo JJ
Antimicrob Agents Chemother; 1991 Jul; 35(7):1356-9. PubMed ID: 1656860
[TBL] [Abstract][Full Text] [Related]
39. In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.
Collins CH; Uttley AH
J Antimicrob Chemother; 1988 Dec; 22(6):857-61. PubMed ID: 3243734
[TBL] [Abstract][Full Text] [Related]
40. Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria.
Sánchez-Carrillo C; Cotarelo M; Cercenado E; Vicente T; Blázquez R; Bouza E
J Antimicrob Chemother; 1996 Jan; 37(1):151-4. PubMed ID: 8647757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
